Tomsitz, D., Livingstone, E., Loquai, C., Kaatz, M., Leiter, U., Schilling, B., . . . Heinzerling, L. (2025). Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma. Journal of the European Academy of Dermatology and Venereology, 39(11), . https://doi.org/10.1111/jdv.20650
Chicago-Zitierstil (17. Ausg.)Tomsitz, Dirk, et al. "Early Termination Does Not Negatively Impact the Outcome of Adjuvant Immunotherapy in Melanoma." Journal of the European Academy of Dermatology and Venereology 39, no. 11 (2025). https://doi.org/10.1111/jdv.20650.
MLA-Zitierstil (9. Ausg.)Tomsitz, Dirk, et al. "Early Termination Does Not Negatively Impact the Outcome of Adjuvant Immunotherapy in Melanoma." Journal of the European Academy of Dermatology and Venereology, vol. 39, no. 11, 2025, https://doi.org/10.1111/jdv.20650.